ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $359,000 | -31.1% | 5,408 | -20.3% | 0.02% | -25.9% |
| Q4 2020 | $521,000 | +50.1% | 6,784 | -15.9% | 0.03% | +35.0% |
| Q3 2020 | $347,000 | -3.1% | 8,067 | -2.8% | 0.02% | -9.1% |
| Q2 2020 | $358,000 | +54.3% | 8,299 | +2.9% | 0.02% | +29.4% |
| Q1 2020 | $232,000 | -54.7% | 8,069 | 0.0% | 0.02% | -39.3% |
| Q4 2019 | $512,000 | +199.4% | 8,069 | +33.3% | 0.03% | +180.0% |
| Q3 2019 | $171,000 | +6.9% | 6,054 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $160,000 | – | 6,054 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |